Daniel Todt
Overview
Explore the profile of Daniel Todt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
2289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Klohn M, Ouwerkerk-Mahadevan S, Jagst M, Vereyken L, Verboven P, et al.
Gastroenterology
. 2024 Nov;
PMID: 39581510
Background & Aims: Hepatitis E virus (HEV) constitutes a substantial public health burden with ∼20 million human infections annually, including 3.3 million symptomatic cases. Appropriate treatment options for, in particular,...
2.
Haase J, Baheerathan A, Zhang X, Fu R, Nocke M, Decker C, et al.
Hepatol Commun
. 2024 Nov;
8(11).
PMID: 39560373
Background: HEV is a positive-sense, single-stranded RNA virus of the Hepeviridae family. Although HEV accounts for more than 3 million symptomatic cases of viral hepatitis per year, specific anti-HEV therapy...
3.
Jagst M, Gomer A, Augustyniak S, Klohn M, Rehm A, Ulrich R, et al.
Proc Natl Acad Sci U S A
. 2024 Nov;
121(47):e2411434121.
PMID: 39546567
Hepatitis E virus (HEV) infections are one of the most common causes of acute viral hepatitis, annually causing over 3 million symptomatic cases and 70,000 deaths worldwide. Historically, HEV was...
4.
Klohn M, Gomer A, He Q, Brown R, Todt D, Wang L, et al.
Antimicrob Agents Chemother
. 2024 Oct;
68(11):e0103524.
PMID: 39360823
Infection with hepatitis E virus (HEV) represents a global problem, with over 20 million people infected annually. No specific antiviral drugs are available for treating HEV infection, necessitating the development...
5.
Kuhn D, Heinen N, Sutter K, Herrmann S, Nocke M, Todt D, et al.
J Med Virol
. 2024 Sep;
96(10):e29935.
PMID: 39323094
Studies have pointed to a decisive role of autoantibodies in the context of sepsis and severe Coronavirus disease 2019 (COVID-19), which itself often fulfills the criteria for sepsis, including dysregulated...
6.
Khanal R, Heinen N, Bogomolova A, Meister T, Herrmann S, Westhoven S, et al.
Liver Int
. 2024 Aug;
44(11):2983-2995.
PMID: 39175256
Background And Aims: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) preferentially infects the respiratory tract; however, several studies have implicated a multi-organ involvement. Hepatic dysfunctions caused by SARS-CoV-2 infection have been...
7.
Meister T, Frericks N, Kleinert R, Rodriguez E, Steinmann J, Todt D, et al.
PLoS Negl Trop Dis
. 2024 Jun;
18(6):e0012264.
PMID: 38900788
Despite continued outbreaks of yellow fever virus (YFV) in endemic regions, data on its environmental stability or guidelines for its effective inactivation is limited. Here, we evaluated the susceptibility of...
8.
Gisevius B, Duscha A, Poschmann G, Stuhler K, Motte J, Fisse A, et al.
Brain Commun
. 2024 Jun;
6(3):fcae182.
PMID: 38894951
Neurodegeneration in the autoimmune disease multiple sclerosis still poses a major therapeutic challenge. Effective drugs that target the inflammation can only partially reduce accumulation of neurological deficits and conversion to...
9.
Plumers R, Dreier J, Knabbe C, Gomer A, Steinmann E, Todt D, et al.
Euro Surveill
. 2024 Jun;
29(24).
PMID: 38873797
BackgroundAwareness of transfusion-transmitted hepatitis E raised in recent years led to the mandatory testing of blood donations in some European countries for hepatitis E virus (HEV) RNA. However, little is...
10.
Schemmerer M, Bock H, Schattenberg J, Huber S, Polywka S, Mader M, et al.
J Med Virol
. 2024 Jun;
96(6):e29735.
PMID: 38864313
Recently, hepatitis E virus (HEV, Paslahepevirus balayani) particles were detected for the first time in the ejaculate of two chronically infected patients. Since then, we have been able to detect...